Please enable Javascript
The HemOnc Pulse
Meeting News
The HemOnc Pulse Live
Video Insights
In Print
Subscribe
Leukemia
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Lymphoma
Aggressive B-Cell Lymphoma
Hodgkin Lymphoma
Indolent B-Cell Lymphoma
Mantle Cell Lymphoma
T-Cell Lymphoma
MPN
Myelofibrosis
Polycythemia Vera
MDS
Myeloma
Transplantation & Cellular Therapy
Sandy Wong, MD
Articles by Sandy Wong, MD
Sandy Wong, MD, on Her Hopes for Patients with Myeloma
Sandy Wong, MD
Myeloma
|
March 29, 2023
Dr. Wong hopes to see an expansion in the availability of new and novel treatments for myeloma.
View More
Sandy Wong, MD, on Advances in Myeloma Treatment
Sandy Wong, MD
Myeloma
|
March 22, 2023
Novel therapies and “game-changing drugs” have made a major impact on the treatment of myeloma, Dr. Wong said.
View More
Sandy Wong, MD, on Raising Myeloma Awareness
Sandy Wong, MD
Myeloma
|
March 28, 2023
Sandy Wong, MD, explains how clinicians and researchers can help educate others about myeloma.
View More
Sandy Wong, MD, on the Meaning of Myeloma Awareness Month
Sandy Wong, MD
Myeloma
|
March 28, 2023
Sandy Wong, MD, explains what Myeloma Awareness Month means to her as a clinician and a researcher.
View More
Sandy Wong, MD, Discusses Phase I Trial of Alnuctamab in Relapsed/Refractory Multiple Myeloma
Cecilia Brown
Video Insights
|
January 11, 2023
Sandy Wong, MD, discusses results from a phase I first-in-human study of alnuctamab in patients with relapsed/refractory MM.
View More